L-1416, a novel MDR reversing agent with possible reduced calcium antagonism
Keywords: آنتاگونیسم کلسیم; MDR, multidrug resistance; VER, verapamil; VBL, vinblastine; DOX, doxorubicin; VCR, vincristineL-1416; P-gp inhibitor; Tumor therapy; Calcium antagonism